Breast Cancers Today podcasts
Dr. Rugo discusses SERENA-6, which showed ctDNA-guided camizestrant extends PFS in HR+/HER2- metastatic breast cancer. Dr. Gradishar reviews PARP data, new combos, and tools to better select breast cancer patients for targeted treatment. Kaele Leonard, a pulmonary/critical care fellow who was diagnosed with breast cancer at a young age, discusses her journey. The Fellow on Call: The Heme/Onc Podcast covers HER2-positive breast cancer in part 11 of its series on breast cancer types. The Fellow on Call: The Heme/Onc Podcast switches from localized breast cancers to metastatic subtypes, starting with ER+. The Fellow on Call Podcast shifts its breast cancer focus to the triple-negative subtype. The Fellow on Call Podcast shifts their focus from ER+ to HER+ breast cancer, detailing treatment options, and much more.